Recombinant Anti-CD20 x Anti-CD47 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD20 IgG with similar domains from an anti-CD47 antibody via short peptide linkers, or vice versa. This BsAb can retarget macrophages to tumor cells. It is designed for the research of Lymphoma therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD20 x Anti-CD47 Bispecific Antibody (Fv-IgG) (BSDG-052). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS